Skip to main content

Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur

    Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.
  • Microorganisms employ a secret weapon during metabolism
    In the global carbon cycle microorganisms have evolved a variety of methods for fixing carbon. Researchers from Bremen and Taiwan have investigated the methods that are utilized at extremely hot, acidic and sulfur-rich hydrothermal vents in shallow waters off the island of Kueishantao, Taiwan.
  • Common genetic variants linked to drug-resistant epilepsy
    Antiseizure medication is usually prescribed for people with the condition. However, for one in three people with epilepsy around 20 million individuals worldwide, current antiseizure medications are ineffective. This means that people will continue to have seizures despite taking medication – a condition called ‘drug resistance.
  • Stevens Researchers Put Glycemic Response Modeling On a Data Diet
    In a paper in the Journal of Diabetes Science and Technology, researchers at Stevens Institute of Technology offer a new approach: a data-sparse model capable of accurately predicting individual glycemic responses with no need for blood draws, stool samples, or other unpleasant testing. The key to their approach? Keeping track of what people actually eat.
  • FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy
    Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy in patients with autoimmune conditions. Patient recruitment for the phase 1 trial will begin soon.
  • Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
    Sandoz the global leader in generic and biosimilar medicines announced the filing of an antitrust lawsuit in the US against Amgen, Inc. , for extending and entrenching the dominant market position of its blockbuster medicine, Enbrel etanercept, first approved by the US Food and Drug Administration in 1998.
  • Starch-based microplastics could cause health risks in mice, study finds
    Wear and tear on plastic products releases small to nearly invisible plastic particles, which could impact people’s health when consumed or inhaled. To make these particles biodegradable, researchers created plastics from plant starch instead of petroleum.
  • Treatment for mitochondrial diseases within reach
    Mitochondrial diseases caused by POLG mutations vary in severity. In young children, these diseases can quickly result in brain damage and life-threatening liver problems while others suffer muscle weakness, epilepsy, and organ failure later in childhood. POLG mutations recently received media attention when Prince Frederik of Nassau in Luxembourg died in March 2025 at just 22 years of age.
  • Pacira BioSciences announces Settlement of U.S. Patent Litigation for EXPAREL
    Pacira BioSciences, Inc. the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has settled its litigations with Fresenius Kabi USA, LLC Fresenius, Jiangsu Hengrui Pharmaceuticals Co., Ltd
  • HKU State Key Laboratory and InnoHK CVVT Successfully Develop Nasal Spray H5N1 Avian Influenza Vaccine
    The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong and the InnoHK Centre for Virology, Vaccinology and Therapeutics have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine.
Subscribe to Pharma News